The Anticoagulant Market is estimated to be valued at US$ 30,773.2 Mn in 2021 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Anticoagulants, also known as blood thinners, are medications used to prevent the formation of blood clots or to treat existing blood clots within the blood vessels. They are commonly prescribed to patients with cardiovascular diseases, atrial fibrillation, deep vein thrombosis, and during surgical procedures. Anticoagulants help in reducing the risk of stroke, heart attack, and other thromboembolic events.
The use cases of anticoagulant products are extensive, ranging from preventive treatment for patients with a high risk of blood clot formation to post-surgical care. These products are widely used in hospitals, clinics, and ambulatory surgical centers.
Market Dynamics:
The high growth of the anticoagulant market can be attributed to two key drivers. Firstly, the rising prevalence of cardiovascular diseases worldwide is driving the demand for anticoagulant medications. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, accounting for around 17.9 million deaths each year.
Secondly, the increasing number of surgeries, such as orthopedic surgeries and cardiac surgeries, is contributing to the growth of the anticoagulant market. Anticoagulants are commonly prescribed during and after surgical procedures to prevent blood clot formation and reduce the risk of complications.
SWOT Analysis:
Strengths:
- Anticoagulant market is experiencing high growth due to increasing prevalence of cardiovascular diseases and thromboembolic disorders.
- Strong demand for anticoagulant drugs from geriatric population.
- Growing adoption of novel oral anticoagulants (NOACs) over traditional anticoagulants due to their better safety profile.
Weaknesses:
- High cost of anticoagulant drugs, especially the NOACs.
- Risk of bleeding and other adverse effects associated with anticoagulant therapy.
Opportunities:
- Increasing research and development activities to develop new anticoagulant drugs with improved safety and efficacy.
- Expanding applications of anticoagulants in treatment of various other diseases such as cancer, stroke, and atrial fibrillation.
Threats:
- Stringent regulatory requirements for approval of anticoagulant drugs.
- Presence of substitutes such as antiplatelet drugs for prevention of clot formation.
Key Takeaways:
The Global Anticoagulant Market Demand is expected to witness high growth, exhibiting a CAGR of 9.4% over the forecast period (2023-2030), due to increasing prevalence of cardiovascular diseases and thromboembolic disorders. The market is dominated by North America, which accounts for the largest market share, driven by high adoption rate of anticoagulant drugs and favorable reimbursement policies. However, Asia Pacific is expected to be the fastest growing region during the forecast period, attributed to rising healthcare expenditure and increasing awareness about anticoagulant therapy.
Key players operating in the anticoagulant market are Pfizer Inc., Sanofi SA, Dr. Reddy’s Laboratories, Aspen Holdings, Abbott Laboratories, Leo Pharma AS, Alexion Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Bristol-Myers Squibb Company, Daiichi Sankyo Company, and Boehringer Ingelheim Pharmaceuticals Inc., among others. These players are focusing on research and development activities to introduce innovative anticoagulant drugs and gain a competitive edge in the market.
Read More:
